353 - Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC)

Autor: Stehn, J., Mariana, A., Failes, T., Ashokakumar, V., Eiffe, E., Heaton, A., Hook, J., Sivanandhan, D., Arndt, G., Gunning, P., Brown, D.
Zdroj: In European Journal of Cancer December 2016 69 Supplement 1:S116-S116
Databáze: ScienceDirect